Publications
[1] das Neves J, Sarmento B, Amiji M, Bahia MF. Development and validation of a HPLC method for the assay of dapivirine in cell-based and tissue permeability experiments. Journal of Chromatography B. 2012; 911(1): 76-83. [2] das Neves J, Rocha CMR, Gonçalves MP, Carrier RL, Amiji M, Bahia MF, Sarmento B. Interactions of microbicide nanoparticles with a simulated vaginal fluid. Molecular Pharmaceutics. 2012; 9(11): 3347-3356. [3] das Neves J, Michiels J, Ariën KK, Vanham G, Amiji M, Bahia MF, Sarmento B. Polymeric nanoparticles affect the intracellular delivery, antiretroviral activity and cytotoxicity of the microbicide drug candidate dapivirine. Pharmaceutical Research. 2012; 29(6): 1468-1484. [4] Sarmento B, Andrade F, Baptista da Silva S, Rodrigues F, das Neves J, Ferreira D. Cell-based in vitro models for predicting drug permeability. Expert Opinion on Drug Metabolism and Toxicology. 2012; 8(5): 607-621. [5] Fonte P, Andrade F, Araújo F, Andrade C, das Neves J, Sarmento B. Chitosan-coated solid lipid nanoparticles for insulin delivery. Methods in Enzymology. 2012; 508: 295-314. [6] Sarmento B, das Neves J. Nanosystem formulations for rectal microbicides: a call for more research. Therapeutic Delivery. 2012; 3(1): 1-4. [7] Andrade F, Goycoolea F, Chiappetta DA, das Neves J, Sosnik A, Sarmento B. Chitosan-grafted copolymers and chitosan-ligand conjugates as matrices for pulmonary drug delivery. International Journal of Carbohydrate Chemistry. 2011; 2011: 865704. [8] Andrade F, Antunes F, Nascimento AV, Baptista da Silva S, das Neves J, Ferreira D, Sarmento B. Chitosan formulations as carriers for therapeutic proteins. Current Drug Discovery and Technology. 2011; 8(3): 157-172. [9] das Neves J, Bahia MF, Amiji MM, Sarmento B. Mucoadhesive nanomedicines: characterization and modulation of mucoadhesion at the nanoscale. Expert Opinion on Drug Delivery. 2011; 8(8): 1085-1104. [10] das Neves J, Amiji M, Sarmento B. Mucoadhesive nanosystems for vaginal microbicide development: friend or foe? Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology. 2011; 3(4): 389-399. [11] das Neves J, Amiji MM, Bahia MF, Sarmento B. Nanotechnology-based systems for the treatment and prevention of HIV/AIDS. Advanced Drug Delivery Reviews. 2010; 62(4-5): 458-577. [12] das Neves J, Sarmento B, Amiji MM, Bahia MF. Development and validation of a rapid reversed-phase HPLC method for the determination of the non-nucleoside reverse transcriptase inhibitor dapivirine from polymeric nanoparticles. Journal of Pharmaceutical and Biomedical Analysis. 2010; 52(2):167-172. [13] das Neves J, Pinto E, Amaral MH, Bahia MF. Antifungal activity of a gel containing Thymus vulgaris essential oil against Candida species commonly involved in vulvovaginal candidosis. Pharmaceutical Biology. 2009; 47(2): 151-153. [14] das Neves J, Vázquez da Silva M, Gonçalves MP, Amaral MH, Bahia MF. Rheological properties of vaginal hydrophilic polymer gels. Current Drug Delivery. 2009; 6(1): 83-92. [15] das Neves J, Pinto E, Teixeira B, Dias G, Rocha P, Cunha T, Santos B, Amaral MH, Bahia MF. Local treatment of vulvovaginal candidosis: general and practical considerations. Drugs. 2008; 68(13): 1787-1802. [16] Amaral MH, das Neves J, Oliveira A, Bahia MF. Foamability and electrical conductivity of detergent solutions prepared with different types of surfactants and waters. Journal of Surfactants and Detergents. 2008; 11(4): 275-278. [17] das Neves J, Amaral MH, Bahia MF. Performance of an in vitro mucoadhesion testing method for vaginal semisolids: influence of different testing conditions and instrumental parameters. European Journal of Pharmaceutics and Biopharmaceutics. 2008; 69(2): 622-632. [18] das Neves J, Santos B, Teixeira B, Dias G, Cunha T, Brochado J. Vaginal drug administration in the hospital setting. American Journal of Health-System Pharmacy. 2008; 65(3): 254-259. [19] das Neves J, Bahia MF. Gels as vaginal drug delivery systems. International Journal of Pharmaceutics. 2006; 318(1-2): 1-14.